Get In Touch


Developing AMCP/Global Value Dossier to Demonstrate Cost and Comparative Effectiveness

AMCP/Global Value dossier is the single source document which communicates clinical, safety, economic and quality of life value proposition of medical products to payers and providers. Due to several recent market events, AMCP/global value dossier has evolved as a powerful tool to present cost and comparative effectiveness data for medical products. We recently conducted a live webinar for discussion on the following topics:

How to prepare comprehensive, concise and clear AMCP/global value dossier for drugs and devices?
How to develop and communicate budget impact model and cost effectiveness analysis using AMCP dossier/GVD?
What are AMCP's latest recommendations for developing dossier?
How to demonstrate comparative effectiveness of your products using AMCP dossier?
Using Evidence Based Medicine to develop robust and powerful AMCP dossiers/GVDs
What strategies can be implemented to easily maintain and update AMCP dossier/GVD with latest clinical and health economic information?
What type of electronic tools (e-dossier, ipad etc) can be used to present AMCP dossier/GVD?
Key findings from Novel Health survey on market access and AMCP dossier/GVD with public and private payer stakeholders
Lessons learned from NOVEL Health Strategies's experience of developing global value dossiers for some of the recently launched blockbusters

Slides from our Webinar are available here:


Event Completed. Request for Dossier Capabilities

A Video Podcast is Available on Quick Takeways Series on Global Value Dossier:




Five Commonly Made Mistakes While Developing Global Value Dossiers: Lesson Learned and Quick Takeaways





Saurabh (Rob) Aggarwal, PhD,

Principal & Co-Founder



NOVEL Won Two Platinum and Bronze Medal Awards at AMCP

NOVEL's team won two Platinum and Bronze Medal Awards for Presentations at AMCP Nexus Educational Conference in Boston

Read More

Podium & Poster Presentations at ISPOR 2015, Philadelphia

NOVEL has been selected for 10 peer-reviewed presentations at ISPOR 2015 meeting in Philaldephila.

Read More

NOVEL Selected for Presentations at AMCP

NOVEL's team was selected for multiple presentations at AMCP. NOVEL is also teaching an educational course on Breakthrough Therapies (CPE credit course). NOVEL also won two Platinum and Bronze Medal Awards!

Read More

NOVEL's Quick Takeaways Series

NOVEL has developed a series of short power insights videos on GVD, Modeling, Strategy and Case Studies. Visit our You tube channel for more information.

Read More

Strategy Overview on Breakthrough Therapy Designations (Nature Biotech)

NOVEL just published a comprehensive overview on all Breakthrough Therapy Designated products, covering their clinical, HEOR, comparative effectiveness and market access.

Read More

Podium & Poster Presentations at HTAi DC

At the Health Technology Assessment HTAi Annual Meeting in Washington, DC, NOVEL's team was selected for podium and poster presentations.

Read More

Annual Strategy Perspective in Nature Biotechnology

Our annual strategy series has been cited and quoted more than two hundred times. Published article is in January issue.

Read More

Market Access & Reimbursement Strategy Seminar in Copenhagen

NOVEL's team and leading healthcare stakeholders hosted a one-day workshop on Market Access & Reimbursement Strategy in Copenhagen (Ministry of Foreign Affairs, Denmark).

Read More